ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $615,000 | -58.9% | 322,130 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,495,000 | -26.3% | 322,130 | -30.6% | 0.00% | 0.0% |
| Q1 2015 | $2,028,000 | +26.0% | 464,260 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,610,000 | +65.5% | 464,260 | +100.0% | 0.00% | +100.0% |
| Q3 2014 | $973,000 | -28.5% | 232,130 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $1,360,000 | -15.7% | 232,130 | -9.4% | 0.00% | 0.0% |
| Q1 2014 | $1,613,000 | +7.7% | 256,100 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,498,000 | +11.0% | 256,100 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,350,000 | -31.5% | 256,100 | 0.0% | 0.00% | -33.3% |
| Q2 2013 | $1,972,000 | – | 256,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |